Itkin, Tomer https://orcid.org/0000-0002-9950-0149
Houghton, Sean https://orcid.org/0000-0001-6385-006X
Schreiner, Ryan https://orcid.org/0000-0002-7457-6606
Lin, Yang https://orcid.org/0000-0002-0709-2468
Badwe, Chaitanya R.
Voisin, Veronique
Murison, Alex
Seyedhassantehrani, Negar https://orcid.org/0009-0008-6718-615X
Kaufmann, Kerstin B. https://orcid.org/0000-0001-5013-6123
Garcia-Prat, Laura
Booth, Gregory T.
Geng, Fuqiang
Liu, Ying
Gomez-Salinero, Jesus M.
Shieh, Jae-Hung
Redmond, David https://orcid.org/0000-0002-0983-8606
Xiang, Jenny Z.
Josefowicz, Steven Z. https://orcid.org/0000-0001-7453-779X
Trapnell, Cole https://orcid.org/0000-0002-8105-4347
Pietras, Eric M. https://orcid.org/0000-0002-7339-8828
Spencer, Joel A. https://orcid.org/0000-0002-4013-8763
Levine, Ross https://orcid.org/0000-0002-7884-1905
Xiao, Wenbin https://orcid.org/0000-0001-8586-8500
Zangi, Lior
Hadland, Brandon
Dick, John E. https://orcid.org/0000-0002-9527-8317
Xie, Stephanie Z. https://orcid.org/0000-0002-0284-494X
Rafii, Shahin https://orcid.org/0000-0001-5605-1067
Article History
Received: 7 September 2022
Accepted: 13 January 2025
First Online: 25 February 2025
Competing interests
: S.R. is the founder and an unpaid consultant to Angiocrine Bioscience. J.E.D. declares research funding from BMS and licensing of SIRP-alpha to Trillium Therapeutics and Pfizer. All other authors declare no competing interests.